AFP and hepatocellular carcinoma: For differentiating AFP-negative early HCC (n = 20) from LC (n = 20), PON1 exhibited an AUROC of 0.850, sensitivity of 90.0%, specificity of 75.0%, and accuracy of 82.5% (94).